Ken Griffin Bio Rad Laboratories, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 11,000 shares of BIO stock, worth $2.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,000
Previous 8,400
30.95%
Holding current value
$2.92 Million
Previous $2.81 Million
28.58%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BIO
# of Institutions
479Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$411 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$277 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$259 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$198 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.53B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...